FIRRM and cholangiocarcinoma: Tumor tissues of bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), glioblastoma multiforme (GBM), HNSC, kidney renal papillary cell carcinoma (KIRP), LIHC, lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), rectum adenocarcinoma (READ), stomach adenocarcinoma (STAD), UCEC (all p < 0.001), cervical squamous cell carcinoma, and endocervical adenocarcinoma (CESC) (p < 0.01) had significantly higher C1ORF112 expression when compared to corresponding normal tissue (Figure 1C).